publication venue for
- The influence of chitosan content in cationic chitosan/PLGA nanoparticles on the delivery efficiency of antisense 2′-O-methyl-RNA directed against telomerase in lung cancer cells 2009
- Mucus-penetrating solid lipid nanoparticles for the treatment of cystic fibrosis: Proof of concept, challenges and pitfalls. 124:125-137. 2018
- Optimizing electrostatic interactions for controlling the release of proteins from anionic and cationically modified alginate. 117:232-243. 2017
- Optimization of controlled release nanoparticle formulation of verapamil hydrochloride using artificial neural networks with genetic algorithm and response surface methodology. 94:170-179. 2015
- Haloperidol-loaded intranasally administered lectin functionalized poly(ethylene glycol)–block-poly(d,l)-lactic-co-glycolic acid (PEG–PLGA) nanoparticles for the treatment of schizophrenia. 87:30-39. 2014
- pH-Dependent doxorubicin release from terpolymer of starch, polymethacrylic acid and polysorbate 80 nanoparticles for overcoming multi-drug resistance in human breast cancer cells. 82:587-597. 2012
- Treatment of lung cancer via telomerase inhibition: Self-assembled nanoplexes versus polymeric nanoparticles as vectors for 2′-O-Methyl-RNA. 80:478-489. 2012
- Photosensitive controlled release with polyethylene glycol–anthracene modified alginate. 79:304-313. 2011
- Extended release of high pI proteins from alginate microspheres via a novel encapsulation technique. 65:329-335. 2007